A 2-Part Single Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006

NCT01463098 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia

Interventions

DRUG: E2006 1.0 mg
DRUG: E2006 2.5 mg
DRUG: E2006 5.0 mg
DRUG: E2006 10.0 mg
DRUG: E2006 25.0 mg
DRUG: E2006 50.0 mg
DRUG: E2006 100 mg
DRUG: E2006 200 mg
DRUG: Zolpidem 10 mg
DRUG: E2006 Matched Placebo or Zolpidem Matched Placebo
DRUG: E2006 Matched Placebo

Sponsor

Eisai Inc.